Systemic administration of HVJ viral coat-liposome complex containing human insulin vector decreases glucose bevel in diabetic mouse: A model of gene therapy

Biochemical and Biophysical Research Communications

Volumn 273, Issue 2, 2000, Pages 666-674

  Morishita, Ryuichi ^a   Gibbons, Gary H ^b   Kaneda, Yasufumi ^a   Ogihara, Toshio ^a   Dzau, Victor J ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Diabetes; Gene therapy; Glucose; Insulin; Sendai virus (HVJ: hemagglutinating virus of Japan)

Indexed keywords

C PEPTIDE; COAT PROTEIN; CREATININE; GLUCOSE; HUMAN INSULIN; LIPOSOME; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EMBRYO; GENE THERAPY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INTRAVENOUS ADMINISTRATION; LIVER; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; SPLEEN; STREPTOZOCIN DIABETES;

ANIMALIA; HUMAN PARAINFLUENZA VIRUS 1; RNA VIRUSES; SENDAI VIRUS;

EID: 0033880445     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2936     Document Type: Article

References (37)

1. Miller A. D. Human gene therapy comes of age. Nature. 357:1992;455-460.
2. Thompson L. At age 2, gene therapy enters a growth phase. Science. 258:1992;744-746.
3. Dzau V. J., Morishita R., Gibbons G. H. Gene therapy in the cardiovascular diseases. Trends Biotech. 11:1993;205-210.
4. Hollingsworth S. J., Barker S. G. Gene therapy: Into the future of surgery. Lancet. 353:1999;SI19-20.
5. Grossman M., Raper S. E., Wilson J. M. Transplantation of genetically modified autologous hepatocytes into nonhuman primates: Feasibility and short-term toxicity. Human Gene Ther. 3:1992;501-510.
6. Kozarsky K. F., Jooss K., Donahee M., Strauss J. F. 3rd, Wilson J. M. Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nat. Genet. 13:1996;54-62.
7. Brown D. R. Adenoviral delivery of low-density lipoprotein receptors to hyperlipidemic rabbits: receptor expression modulates high-density lipoproteins. Metabolism. 45:1996;1447-1457.
8. Kozarsky K. F. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269:1994;13695-13702.
9. Kaneda Y., Iwai K., Uchida T. Introduction and expression of the human insulin gene in adult rat liver. J. Biol. Chem. 264:1989;12126-12129.
10. Smith T. A. G. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5:1993;3397-3402.
11. Ilan Y., Saito H., Thummala N. R., Chowdhury N. R. Adenovirus-mediated gene therapy of liver diseases. Semin. Liver Dis. 19:1999;49-59.
12. Muruve D. A., Barnes M. J., Stillman I. E., Libermann T. A. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10:1999;965-976.
13. Kaneda Y., Iwai K., Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science. 243:1989;375-378.
14. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1992;193-200.
15. Morishita R., Gibbons G. H., Kaneda Y., Ogihara T., Dzau V. J. Novel and effective gene transfer technique for study of vascular renin angiotensin system. J. Clin. Invest. 91:1993;2580-2585.
16. Kato K., Nakanishi Y., Kaneda Y., Uchida T., Okada Y. Expression of hepatitis B virus surface antigen in adult rat liver. J. Biol. Chem. 266:1991;3361-3364.
17. Kato K., Kaneda Y., Sakurai M., Nakanishi M., Okada Y. Direct injection of hepatitis B virus DNA into liver induced hepatitis in adult rats. J. Biol. Chem. 266:1991;22071-22074.
18. Morishita R. Single intraluminal delivery of antisense cdc 2 kinase and PCNA oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA. 90:1993;8474-8478.
19. Tomita N. Direct in vivo gene introduction into rat kidney. Biochem. Biophys. Res. Commun. 186:1992;129-134.
20. Kuzuya H., Blix P. M., Horwitz D. L., Steiner D. F., Rubenstein A. H. Determination of free and total insulin and C-peptide in insulin treated diabetics. Diabetes. 26:1977;22-29.
21. Coker G. T., Studelska D., Harmon S., Bruke W., O'Malley K. L. Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Mol. Brain Res. 8:1990;93-98.
22. D'agostino J., Field J. B., Franzier M. L. Ontogeny of immunoreactive insulin in the fetal bovine pancreas. Endocrinology. 116:1985;1108-1116.
23. Iwamoto H. S., Trapnell B. C., McConnell C. J., Daugherty C., Whitsett J. A. Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep. Gene Ther. 6:1999;98-106.
24. Mittal S. K., McDermott M. R., Johnson D. C., Prevec L., Graham F. L. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase as a reporter. Virus Res. 28:1993;67-90.
25. Selden R. F., Skoskiewicz M. J., Russell P. S., Goodman H. M. Regulation of insulin-gene expression. Implications for gene therapy. N. Engl. J. Med. 317:1987;1067-1076.
26. Strattford-Perricaudet L. D., Makeh I., Perricaudet M., Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90:1992;626-630.
27. Stratford-Perricaudet L. D., Levrero M., Chasse J., Perricaudet M. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1:1990;241-256.
28. Zhu N., Liggitt D., Liu Y., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 261:1993;209-211.
29. Hadjidakis D. J., Raptis S. A. Proinsulin as a possible therapeutic agent. Hormone Metab. Res. S26:1992;131-137.
30. Yanagita M., Hoshino H., Nakayama K., Takeuchi T. Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin reflects the expression of furin in nonendocrine cell lines. Endocrinology. 133:1993;639-644.
31. Yanagita M., Nakayama K., Takeuchi T. Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non-endocrine cell line, COS-7. FEBS Lett. 311:1992;55-59.
32. Yao S. N., Kurachi K. Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc. Natl. Acad. Sci. USA. 89:1992;3357-3361.
33. Barr J., Leiden J. M. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science. 254:1991;1507-1509.
34. Dhawan J. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science. 254:1991;1509-1512.
35. Dai Y., Roman M., Naviaux R. K., Verma I. M. Long term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA. 89:1992;10892-10895.
36. Taniguchi H., Nakauchi H., Iwata H., Amemiya H., Fukao K. Treatment of diabetic mice with encapsulated fibroblasts producing human proinsulin. Transplant Proc. 24:1992;2977-2978.
37. Kawakami Y. Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes. 41:1992;956-961.